Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
172,290,053
-
Shares change
-
-1,026,048
-
Total reported value, excl. options
-
$2,929,156,988
-
Value change
-
-$17,045,988
-
Put/Call ratio
-
38%
-
Number of buys
-
103
-
Number of sells
-
-122
-
Price
-
$17.00
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q4 2020
293 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 172,290,053 shares
.
Largest 10 shareholders include Invesco Ltd. (35,456,949 shares), FMR LLC (18,949,685 shares), PRIMECAP MANAGEMENT CO/CA/ (18,440,399 shares), BlackRock Inc. (18,378,080 shares), VANGUARD GROUP INC (16,272,585 shares), WELLINGTON MANAGEMENT GROUP LLP (13,392,612 shares), MAVERICK CAPITAL LTD (6,655,625 shares), STATE STREET CORP (4,475,576 shares), Bellevue Group AG (3,866,258 shares), and FIRST TRUST ADVISORS LP (3,814,215 shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.